Dimensional Fund Advisors
MRNS

Dimensional Fund Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Dimensional Fund Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,201
Closed -$317K – 3439
2023
Q4 		$317K Sell
29,201
-2,888
-9% -$21.6K ﹤0.01% 3120
2023
Q3 		$258K Hold
32,089
– – ﹤0.01% 3169
2023
Q2 		$348K Hold
32,089
– – ﹤0.01% 3134
2023
Q1 		$221K Hold
32,089
– – ﹤0.01% 3184
2022
Q4 		$128 Buy
+32,089
New +$158K ﹤0.01% 3296
2022
Q3 		– Sell
-74,511
Closed -$360K – 3537
2022
Q2 		$360K Sell
74,511
-13,874
-16% -$84.4K ﹤0.01% 3140
2022
Q1 		$826K Hold
88,385
– – ﹤0.01% 3033
2021
Q4 		$1.05M Buy
88,385
+42,254
+92% +$488K ﹤0.01% 3021
2021
Q3 		$525K Sell
46,131
-42,776
-48% -$588K ﹤0.01% 3167
2021
Q2 		$1.59M Buy
88,907
+28,059
+46% +$451K ﹤0.01% 2933
2021
Q1 		$941K Sell
60,848
-2,369
-4% -$34.3K ﹤0.01% 3026
2020
Q4 		$771K Buy
63,217
+29,188
+86% +$407K ﹤0.01% 3026
2020
Q3 		$436K Sell
34,029
-6,994
-17% -$60.4K ﹤0.01% 3086
2020
Q2 		$417K Sell
41,023
-5,650
-12% -$52K ﹤0.01% 3111
2020
Q1 		$379K Sell
46,673
-9,217
-16% -$79.8K ﹤0.01% 3104
2019
Q4 		$483K Sell
55,890
-4,499
-7% -$25.2K ﹤0.01% 3136
2019
Q3 		$372K Buy
60,389
+6,319
+12% +$51.1K ﹤0.01% 3191
2019
Q2 		$898K Buy
54,070
+43,577
+415% +$757K ﹤0.01% 3075
2019
Q1 		$175K Hold
10,493
– – ﹤0.01% 3326
2018
Q4 		$120K Sell
10,493
-3,112
-23% -$63K ﹤0.01% 3345
2018
Q3 		$544K Buy
+13,605
New +$387K ﹤0.01% 3167
2018
Q2 		– Sell
-3,775
Closed -$58K – 3383
2018
Q1 		$58K Hold
3,775
– – ﹤0.01% 3310
2017
Q4 		$123K Hold
3,775
– – ﹤0.01% 3265
2017
Q3 		$89K Buy
+3,775
New +$42.3K ﹤0.01% 3289

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Dimensional Fund Advisors's MRNS Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2024, closing a stake of 29,201 shares — an estimated $317K sold.

Dimensional Fund Advisors first reported a position in MRNS in Q3 2017 and held it in 24 quarters. The position peaked at $1.59M in Q2 2021. 112 funds tracked by Wall St. Rank hold MRNS as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 29,201 Marinus Pharmaceuticals, Inc shares in Q1 2024, an estimated $317K.
  • Dimensional Fund Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 24 quarters.
  • Dimensional Fund Advisors's Marinus Pharmaceuticals, Inc position peaked at $1.59M in Q2 2021.
  • 112 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.